23948sdkhjf
  • {{ window.visitor.corporateClient.name }}
    Corporate solution
    {{ window.visitor.ipAccess.corporateClient.name }}
    {{ window.visitor.corporateClient.name }}

  • Welcome to our Corporate client solution

    Here you can administrate your corporate solutions users.

  • Welcome to your subscription for Life Science Focus

  • Welcome to our Corporate client solution

    Your IP is registered with the company mentioned above and provides access to Life Science Focus.

  • Click here to go to sign-up
Log in or create to bookmark articles
Get access to all content on Life Science Focus
No commitment or card information required
Try Life Science Focus now
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement
People & Careers

AlzeCure CEO steps down – co-founder takes over

Two multibillion-dollar deals, the company’s first profit and an oversubscribed share issue. After an eventful year, AlzeCure Pharma is changing CEO. Martin Jönsson is stepping down after almost seven years and will be temporarily replaced by Chief Scientific Officer and co-founder Johan Sandin.
Advertisement

The board and Martin Jönsson, who has served as CEO of AlzeCure Pharma since January 2020, have mutually agreed that he will step down, according to a press release.

He will be replaced on an interim basis by Chief Scientific Officer and co-founder Johan Sandin, who has previously served as the company’s CEO. At the same time, Pontus Forsell, currently Head of Discovery & Research, has been appointed Deputy CEO.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.047|